Abstract: It was synthesized N-[5-(4-fluorobenzyl)-1,3-thiazol-2-yl]chroman-3-carboxamide. The 
structure of the title compound was confirmed by 1H NMR spectroscopy and elemental analysis. The 
synthesized compound complies with Lipinski, Muegge, Ghose, Veber, and Egan rules. ADME and 
toxicity of the compound are analyzed, and Swiss target prediction of the compound has been carried 
out to analyze the preferred target. The title compound exhibited remarkable anticancer activity against 
all the tested cell lines and was more active than classical anticancer drugs – gefitinib, 5-fluorouracil, 
cisplatin, and curcumin. The metabolic pathway mediated by Cytochrome P450 was evaluated for the 
title compound. It was found that the main pathways are aromatic hydroxylation of fused benzene ring, 
which should not cause toxic effects.  
Keywords: thiazole; chroman; virtual screening; drug-like molecules; anticancer activity; 
Cytochrome P450; metabolism.